Glaukos's EBIT per Share for the
three
months ended in Dec. 2023 was $-0.68.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.48.
During the past 3 years, the average EBIT per Share Growth Rate was 1.50% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -37.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Glaukos's EBIT per Share or its related term are showing as below:
GKOS'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -247.8 Med: -11.6 Max: 50
Current: 1.5
During the past 11 years, the highest 3-Year average EBIT per Share Growth Rate of Glaukos was 50.00% per year. The lowest was -247.80% per year. And the median was -11.60% per year.
GKOS's 3-Year EBIT Growth Rate is ranked worse than 58.01% of 724
companies
in the Medical Devices & Instruments industry
Industry Median: 6.75
vs GKOS: 1.50
Glaukos's EBIT for the
three
months ended in Dec. 2023 was $-33.3 Mil.
Glaukos EBIT per Share Historical Data
The historical data trend for Glaukos's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.48
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Glaukos (NYSE:GKOS) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Glaukos EBIT per Share Related Terms
Thank you for viewing the detailed overview of Glaukos's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GKOS has been successfully added to your 